Join
Live feed
·
PRReleasevia Quantisnow
TScan Therapeutics Inc. logo

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

ByQuantisnow·Wall Street's wire, on your screen.
TCRX· TScan Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRX (TScan Therapeutics Inc.) and more on Quantisnow.